Sabriya is Chief Scientific Officer at IndieBioNY. Prior to joining, she was Operations Director for Stellate Therapeutics, a biotech company developing microbiome-derived therapeutics to treat neurodegenerative diseases. After earning her PhD in Biomedical Sciences from the Albert Einstein College of Medicine, she was the founding Associate Director for the Master’s in Translational Medicine (MTM) program at The City College of New York, NYC’s first and only graduate degree that educates and trains scientists and engineers in the hands-on process of medical technology commercialization and healthcare innovation.
A microbiologist, educator, and science communicator, her expertise is in working with individuals to identify unmet community needs, design sustainable clinical solutions, think critically about the world around them, and craft compelling scientific narratives. She also has worked for over a decade in fostering equitable and inclusive environments in the STEM disciplines and thinks deeply about how we can build sustainable healthcare solutions that work for all and not just some.